Home Health & Hospice Week

People:

McClellan To Take CMS Top Post Amid Drug Controversy

It wasn't pretty, but it's official. Mark McClellan, MD, is the new Centers for Medicare & Medicaid Services Administrator. The Senate confirmed McClellan by voice vote March 11, after Sen. Byron Dorgan (D-ND) released the hold he had placed on the nomination over McClellan's refusal to testify before the Senate Commerce Committee regarding the importation of cheaper Food and Drug Administration-approved drugs from abroad without the manufacturer's consent. Dorgan favors allowing importation -- often called "reimportation" because most of the drugs originate from U.S. plants -- while McClellan has consistently said the FDA does not have the resources or authority under current law to ensure the drugs' safety. McClelland has headed the FDA since November 2002. McClellan, who had said he would appear in front of Commerce only after being confirmed as CMS administrator, reversed course and testified there in a contentious hearing March 11. "Many who have met McClellan, including [National Association for Home Care and Hospice] President Val J. Halamandaris, have a favorable impression of him and speculate that he will be supportive of home health and hospice services," NAHC says.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more